Clozapine-associated emergency
Agranulocytosis / myocarditis · Psychiatry / Behavioural
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Clozapine can cause life-threatening agranulocytosis, myocarditis (especially in the first weeks), severe constipation/ileus, seizures and toxicity. Any unwell clozapine patient needs FBC, an ECG/troponin and a low threshold to stop the drug.
Assessment
Investigations
- FBC (neutropenia/agranulocytosis)
- ECG + troponin + CRP (myocarditis)
- Assess for ileus/constipation
- Clozapine level if toxicity suspected
Management
- Stop clozapine if agranulocytosis, myocarditis or severe toxicity
- Neutropenic sepsis pathway if febrile and neutropenic
- Treat myocarditis supportively; cardiology involvement
- Manage constipation/ileus aggressively (risk of perforation)
- Liaise with psychiatry before restarting
Drugs & doses
Empirical antibiotics per BNF — see the in-app Antibiotic Dosing tool
Supportive care
Disposition
Medical admission; liaise psychiatry.
A breathless or febrile patient in the first weeks of clozapine - exclude myocarditis and agranulocytosis before anything else. Antibiotic doses per BNF (current edition); confirm choice in the in-app Antibiotic Dosing tool.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.